首页> 外文OA文献 >DOP39 The first prospective, multicentre, randomised controlled trial on discontinuation of infliximab in ulcerative colitis in remission; endoscopic normalisation does not guarantee successful withdrawal

【2h】

DOP39 The first prospective, multicentre, randomised controlled trial on discontinuation of infliximab in ulcerative colitis in remission; endoscopic normalisation does not guarantee successful withdrawal

机译：DOP39第一前期，多期形，随机对照试验，用于缓解溃疡性结肠炎中溃疡性结肠炎;内窥镜归一化不能保证成功退出

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
T Kobayashi; S Motoya; S Nakamura; T Yamamoto; M Nagahori; S Tanaka; T Hisamatsu; F Hirai; H Nakase; K Watanabe; T Matsumoto; M Tanaka; T Abe; Y Suzuki; M Watanabe; T Hibi;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial [J] . Casper Steenholdt, J?rn Brynskov, Klaus Bendtzen, BMJ Open . 2014,第12期

机译：在持续完全缓解的克罗恩病患者中终止英夫利昔单抗治疗（STOP IT研究）：一项双盲，随机，安慰剂对照，多中心试验的方案
2. Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial [J] . Casper Steenholdt, J?rn Brynskov, Klaus Bendtzen, BMJ Open . 2014,第12期

机译：在持续完全缓解的克罗恩病患者中终止英夫利昔单抗治疗（STOP IT研究）：一项双盲，随机，安慰剂对照，多中心试验的方案
3. Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis [J] . Peter Doran, Carol Ann Coe, Garret Cullen, BMJ Open Gastroenterology . 2018,第1期

机译：一项多中心随机对照试验的协议，该协议研究针对溃疡性结肠炎中炎症负荷量身定制的个性化golimumab剂量的使用：GOAL-ARC研究（GLM剂量优化至足以达到结肠炎反应的水平）
4. Synbiotic Therapy Significantly Reduces Molecular Markers of Inflammation and Clinical Scores in Patients with Active Ulcerative Colitis; A Randomised Controlled Trial [C] . Controlled Release Society annual meeting . 2004

机译：同步治疗显着减少了活性溃疡性结肠炎患者的炎症和临床评分的分子标记;随机对照试验
5. Discontinuation of infliximab therapy in patients with Crohns disease in sustained complete remission (the STOP IT study): protocol for a double-blind randomised placebo-controlled multicentre trial [O] . Sine Schnoor Buhl, Casper Steenholdt, Jørn Brynskov, 2014

机译：在持续完全缓解的克罗恩病患者中终止英夫利昔单抗治疗（STOP IT研究）：一项双盲随机安慰剂对照多中心试验的方案
6. Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis:Trial design and protocol (CONSTRUCT) [O] . Seagrove Anne C, Alam M Fasihul, Alrubaiy Laith, 2014

机译：随机对照试验。 iNfliximab和环孢素在类固醇抵抗性溃疡性结肠炎中的比较：试验设计和方案（CONSTRUCT）

DOP39 The first prospective, multicentre, randomised controlled trial on discontinuation of infliximab in ulcerative colitis in remission; endoscopic normalisation does not guarantee successful withdrawal

著录项

相似文献

相关主题

期刊订阅